These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30131305)

  • 1. IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3).
    van den Berg VJ; Haskard DO; Fedorowski A; Hartley A; Kardys I; Caga-Anan M; Akkerhuis KM; Oemrawsingh RM; van Geuns RJ; de Jaegere P; van Mieghem N; Regar E; Ligthart JMR; Umans VAWM; Serruys PW; Melander O; Boersma E; Khamis RY
    EBioMedicine; 2018 Oct; 36():63-72. PubMed ID: 30131305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of Autoantibodies to MDA-LDL and ApoB-Immune Complexes to Sex, Ethnicity, Subclinical Atherosclerosis, and Cardiovascular Events.
    Prasad A; Clopton P; Ayers C; Khera A; de Lemos JA; Witztum JL; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1213-1221. PubMed ID: 28473443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Biomarker and Imaging Study 3 (IBIS-3) to assess the ability of rosuvastatin to decrease necrotic core in coronary arteries.
    Oemrawsingh RM; Garcia-Garcia HM; van Geuns RJ; Lenzen MJ; Simsek C; de Boer SP; Van Mieghem NM; Regar E; de Jaegere PP; Akkerhuis KM; Ligthart JM; Zijlstra F; Serruys PW; Boersma E
    EuroIntervention; 2016 Aug; 12(6):734-9. PubMed ID: 27542785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events.
    Tsimikas S; Brilakis ES; Lennon RJ; Miller ER; Witztum JL; McConnell JP; Kornman KS; Berger PB
    J Lipid Res; 2007 Feb; 48(2):425-33. PubMed ID: 17093289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Serum Immunoglobulin G and M Levels Predict Freedom From Adverse Cardiovascular Events in Hypertension: A Nested Case-Control Substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Khamis RY; Hughes AD; Caga-Anan M; Chang CL; Boyle JJ; Kojima C; Welsh P; Sattar N; Johns M; Sever P; Mayet J; Haskard DO
    EBioMedicine; 2016 Jul; 9():372-380. PubMed ID: 27333022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auto-Antibody Production During Experimental Atherosclerosis in
    Hutchinson MA; Park HS; Zanotti KJ; Alvarez-Gonzalez J; Zhang J; Zhang L; Telljohann R; Wang M; Lakatta EG; Gearhart PJ; Maul RW
    Front Immunol; 2021; 12():695220. PubMed ID: 34305930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis.
    Cvetkovic JT; Wållberg-Jonsson S; Ahmed E; Rantapää-Dahlqvist S; Lefvert AK
    Rheumatology (Oxford); 2002 Sep; 41(9):988-95. PubMed ID: 12209031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced IgM levels and elevated IgG levels against oxidized low-density lipoproteins in HIV-1 infection.
    Yilmaz A; Jennbacken K; Fogelstrand L
    BMC Infect Dis; 2014 Mar; 14():143. PubMed ID: 24636004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating malondialdehyde-modified low-density lipoprotein levels are associated with the presence of thin-cap fibroatheromas determined by optical coherence tomography in coronary artery disease.
    Matsuo Y; Kubo T; Okumoto Y; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Kitabata H; Hirata K; Imanishi T; Akagi H; Akasaka T
    Eur Heart J Cardiovasc Imaging; 2013 Jan; 14(1):43-50. PubMed ID: 22573905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.
    McDowell A; Young IS; Wisdom GB
    J Pharm Pharmacol; 2002 Dec; 54(12):1651-7. PubMed ID: 12542895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibodies against modified low-density lipoproteins and their complexes in blood of patients with various manifestations of atherosclerosis].
    Belik IV; Ivantsova AA; Mamedova ZE; Denisenko AD
    Biomed Khim; 2016 May; 62(4):471-5. PubMed ID: 27563003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malondialdehyde-Modified LDL IgG Antibody Levels and Indices of Cardiac Function in Valvular Heart and Coronary Artery Disease Patients.
    Rahsepar AA; Mirzaee A; Moodi F; Moohebati M; Tavallaie S; Khorashadizadeh F; Mottahedi B; Esfehanizadeh J; Azari A; Khojasteh R; Mousavi S; Paydar R; Amini M; Ghayour-Mobarhan M; Ferns GA; Sahebkar A
    Med Princ Pract; 2015; 24(5):424-31. PubMed ID: 26139161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PCSK9 in relation to coronary plaque inflammation: Results of the ATHEROREMO-IVUS study.
    Cheng JM; Oemrawsingh RM; Garcia-Garcia HM; Boersma E; van Geuns RJ; Serruys PW; Kardys I; Akkerhuis KM
    Atherosclerosis; 2016 May; 248():117-22. PubMed ID: 27015246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome: Results of the ATHEROREMO-IVUS study.
    Cheng JM; Suoniemi M; Kardys I; Vihervaara T; de Boer SP; Akkerhuis KM; Sysi-Aho M; Ekroos K; Garcia-Garcia HM; Oemrawsingh RM; Regar E; Koenig W; Serruys PW; van Geuns RJ; Boersma E; Laaksonen R
    Atherosclerosis; 2015 Dec; 243(2):560-6. PubMed ID: 26523994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease.
    Boullier A; Hamon M; Walters-Laporte E; Martin-Nizart F; Mackereel R; Fruchart JC; Bertrand M; Duriez P
    Clin Chim Acta; 1995 Jun; 238(1):1-10. PubMed ID: 7554289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Malondialdehyde-Modified Low-Density Lipoprotein on Tissue Characteristics in Patients With Stable Coronary Artery Disease　- Integrated Backscatter-Intravascular Ultrasound Study.
    Ikenaga H; Kurisu S; Kono S; Sumimoto Y; Watanabe N; Shimonaga T; Higaki T; Iwasaki T; Mitsuba N; Ishibashi K; Dohi Y; Fukuda Y; Kihara Y
    Circ J; 2016 Sep; 80(10):2173-82. PubMed ID: 27581176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human IgM Antibodies to Malondialdehyde Conjugated With Albumin Are Negatively Associated With Cardiovascular Disease Among 60-Year-Olds.
    Thiagarajan D; Frostegård AG; Singh S; Rahman M; Liu A; Vikström M; Leander K; Gigante B; Hellenius ML; Zhang B; Zubarev RA; de Faire U; Lundström SL; Frostegård J
    J Am Heart Assoc; 2016 Dec; 5(12):. PubMed ID: 27998914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study.
    Choi SH; Chae A; Miller E; Messig M; Ntanios F; DeMaria AN; Nissen SE; Witztum JL; Tsimikas S
    J Am Coll Cardiol; 2008 Jul; 52(1):24-32. PubMed ID: 18582631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study.
    Räber L; Taniwaki M; Zaugg S; Kelbæk H; Roffi M; Holmvang L; Noble S; Pedrazzini G; Moschovitis A; Lüscher TF; Matter CM; Serruys PW; Jüni P; Garcia-Garcia HM; Windecker S;
    Eur Heart J; 2015 Feb; 36(8):490-500. PubMed ID: 25182248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of malondialdehyde-modified low-density lipoprotein on coronary plaque vulnerability in patients not receiving lipid-lowering therapy: a whole coronary analysis with multislice-computed tomography.
    Ito T; Ichihashi T; Fujita H; Sugiura T; Ohte N
    Heart Vessels; 2018 Apr; 33(4):351-357. PubMed ID: 29067491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.